机器人辅助根治性膀胱切除术与开放根治性膀胱切除术:肿瘤学、围手术期及并发症相关结局的Meta分析
该Meta分析整合随机对照试验数据,比较机器人辅助根治性膀胱切除术(RARC)与开放根治性膀胱切除术(ORC)的结局。RARC与ORC在无复发生存/无进展生存(HR 0.89,95%CI 0.64-1.24)、手术切缘率或淋巴结清扫数目上无差异;RARC估计失血量有优势但手术时间更长,住院时间和并发症率无差异。复发模式分析显示两组在(盆腔)与远处/腹部复发部位上存在显著差异(p=0.04),但该分析为事后分析且研究间复发部位定义不一致,需谨慎解读。
要点
- RARC与ORC在无复发生存/无进展生存上无差异(HR 0.89,95%CI 0.64-1.24)。
- RARC估计失血量有优势,但手术时间更长,住院时间和并发症率无差异。
- 复发模式分析显示两组在(盆腔)与远处/腹部复发部位上存在显著差异(p=0.04),但为事后分析且定义不一致,需谨慎解读。
核心结论
- 这些数据支持RARC的肿瘤学安全性;然而,需要进一步研究评估复发模式的潜在差异。
研究设计与样本
- 本研究为对随机对照试验(RCT)进行的Meta分析,比较RARC与ORC的患者结局。
主要发现
- RARC与ORC在无复发生存/无进展生存上无差异(HR 0.89,95%CI 0.64-1.24)。
- RARC与ORC在手术切缘率或淋巴结清扫数目上无差异。
- 复发模式分析显示(盆腔)与远处/腹部复发部位在RARC与ORC之间存在显著差异(p=0.04)。
- RARC在估计失血量上有优势,但手术时间更长。
- RARC与ORC在住院时间或并发症率上无差异。
局限性
- 复发模式分析为结合RCT数据的事后分析,且研究间复发部位定义不一致,必须谨慎解读。
- 需要进一步研究评估复发模式的潜在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Robot-assisted radical cystectomy (RARC) is increasingly being used to treat muscle-invasive bladder cancer in an attempt to improve functional outcomes and complication rates over open radical cystectomy (ORC). We performed a meta-analysis of randomized controlled trials (RCTs) to compare patient outcomes between RARC and ORC. The primary outcome measure was a composite of recurrence-free survival (RFS) or progression-free survival (PFS). As a secondary measure, we examined other surrogate oncologic endpoints, perioperative outcomes, and complications. We found no difference between RARC and ORC with respect to RFS/PFS (hazard ratio 0.89, 95% confidence interval 0.64-1.24), surgical margin rates, or lymph node dissection yield. Analysis of patterns of recurrence for (pelvic) versus distant/abdominal sites indicated a significant difference between RARC and ORC (p=0.04). This analysis represents a combination of post hoc analyses using RCT data and inconsistent between-study definitions of recurrence sites, and must be interpreted with caution. Lastly, RARC was associated with an advantage in estimated blood loss, but a longer operative time, with no difference in hospital length of stay or complication rates. These data support the oncologic safety of RARC; however, further research is required to assess potential differences in recurrence patterns. PATIENT SUMMARY: We synthesized data from recent randomized controlled trials to examine differences in cancer control between minimally invasive, robot-assisted radical cystectomy and traditional, open radical cystectomy. Our study shows that cancer control outcomes are comparable between robotic and open techniques, supporting the safety of minimally invasive surgery. Blood loss was lower in robotic surgery, but the robotic procedure was longer and did not have lower complications rates after surgery.
引用
- Satkunasivam R, Tallman CT, Taylor JM, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes. Eur Urol Oncol. 2018. PMID: 31277781. doi:10.1016/j.euo.2018.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。